Skip to Content

Money

Pfizer expects to rake in sales of $15 billion from its Covid-19 vaccine this year

Pfizer expects to earn approximately $15 billion in revenue from its Covid-19 vaccine this year, the company said Tuesday. Its fourth-quarter earnings report was the first since Pfizer’s Covid-19 vaccine received emergency-use authorization from the US Food and Drug Administration in December — the first vaccine to receive such approval. Since then, the vaccine, developed

Continue Reading
Skip to content